Clinical trial

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

NCT01209026

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-23

PhasePHASE1

Study timeline

Study start (actual)2010-06-23Date precision: day

Registry last updated2017-06-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

Fluticasone furoate (200 mcg)/GW642444 (25mcg) combinationDRUG

Fluticasone furoate (400 mcg)/GW642444 (50mcg) combinationDRUG

Placebo InhalerDRUG

Moxifloxacin 400mgDRUG

Moxifloxacin placeboDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01209026 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.